Innoviva (INVA) Return on Equity [ROE] (2012 - 2026)
Innoviva's Return on Equity [ROE] was 27.75% in Q2 2026, up 22.07 percentage points from 5.68% a year earlier but down 12.37 percentage points from the prior quarter.
Powered by 
Analysis
Innoviva (INVA) Return on Equity [ROE] (2012 - 2026) Analysis & Trends
For FY2025, Return on Equity [ROE] at Innoviva came in at 29.09%, up 25.67 percentage points from FY2024.
- Return on Equity [ROE] shows a five-year change of -32.76 percentage points (FY2020 to FY2025).
- In earlier years, Return on Equity [ROE] was 3.42% in FY2024 (-24.17 pp), 27.60% in FY2023 (-8.90 pp), 36.49% in FY2022 (-28.57 pp) and 65.06% in FY2021 (+3.21 pp).
- Quarterly Return on Equity [ROE] has moved between -8.93% (Q1 2025) and 89.93% (Q3 2021) over five years.
- Compared with a year earlier, Return on Equity [ROE] has increased for four straight quarters, with an average year-over-year change of +9.40 percentage points over the last six quarters.
- The best year-over-year quarter for Return on Equity [ROE] over five years was Q1 2026 (a gain of 49.04 percentage points); the worst was Q2 2024 (a drop of 33.26 percentage points).
- Per Business Quant data, INVA's Return on Equity [ROE] in the three quarters before Q2 2026 was 40.11% (Q1 2026), 24.85% (Q4 2025) and 14.77% (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROE (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 25.32% |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | - |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 7.21% |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 84.40% |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 21.39% |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 83.75% |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | -18.38% |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 4.97% |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 22.24% |
| 10 | Innoviva | 1.54 Bn | -750.13 Mn | 90.62 Mn | 27.75% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 27.75% |
| Mar 31, 2026 | 40.11% |
| Dec 31, 2025 | 24.85% |
| Sep 30, 2025 | 14.77% |
| Jun 30, 2025 | 5.68% |
| Mar 31, 2025 | -8.93% |
| Dec 31, 2024 | 3.44% |
| Sep 30, 2024 | 12.76% |
| Jun 30, 2024 | 12.44% |
| Mar 31, 2024 | 22.45% |
| Sep 30, 2023 | 18.24% |
| Jun 30, 2023 | 45.70% |
| Mar 31, 2023 | 48.84% |
| Dec 31, 2022 | 46.10% |
| Sep 30, 2022 | 55.39% |
| Jun 30, 2022 | 37.13% |
| Mar 31, 2022 | 55.09% |
| Dec 31, 2021 | 72.48% |
| Sep 30, 2021 | 89.93% |
| Jun 30, 2021 | 61.84% |
API Access
Innoviva Return on Equity [ROE] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=INVA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-equity-[roe]", "ticker": "INVA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=INVA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();